Last checked at 
Shares in the brain health software products developer dropped 18% at
For the year, the company swung to a pretax loss of
Revenue for the year fell slightly to
"While revenue was broadly flat on the prior year, the growth of service revenues and the revenue generated from new products reflects the business plan implemented over the last two years. The growth in sales orders received also demonstrates that we continue to broaden our customer base," said Chief Executive Officer Steven Powell.
"We have increased our investment in research and development activity in the year. This has yielded significant advances in both our neuroscience programmes and our technology platforms. Our progress in both of these areas opens the possibilities of a wider range of commercial relationships than previously available to us," Powell added.
